📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
30%
🔄 Reverse Split
40%
• 50-day avg $1.07 approaching $1 threshold
• 6 months cash with weak price
📉 Score Deterioration
25%
• Score increased 14 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (6mo)
💹 Market Data
Market Cap$18.44M
Shares Outstanding10.01M
Float6.88M
Cash$1.92M
Debt$8.00M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 39.3% shares (2025Q4 vs prior)
4 institutional holders · 97.4K shares
#1
CITADEL ADVISORS LLC
54.1K shares
#2
XTX Topco Ltd
31.8K shares
#3
Moors & Cabot, Inc.
10.0K shares
+ 1 more holders Sign up free to view →
📉 Short Interest
Short Interest1.04M
Days to Cover1.0
% of Float15.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for STAK
📊 STAK FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 STAK Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.